RNA interference: An Ancient Mechanism for Novel Therapeutics
The Internet Journal of Genomics and Proteomics · 2007
DOI: 10.5580/13ef ↗At a glance
Journal article in The Internet Journal of Genomics and Proteomics, 2007.
Abstract (original language)
The siRNA approach for gene silencing holds great therapeutic promise, since siRNAs, like miRNAs, are naturally used by cells to regulate gene expression and hence are expected to be nontoxic and highly effective. Their therapeutic potential can be exploited maximally only when the mechanism underlying their localized and systemic activity is fully understood. Lower eukaryotes provide good model systems yet species specificity leading to minor differences at mechanistic level, point to their being investigated in mammalian milleu. In vitro cellular level studies have proven the therapeutic potential of iRNA to a larger extent. At present only one topical drug Vitravene targeting AMD is in market and several other RNAi based drugs are in the pipeline.
Cite
APA
(2007). RNA interference: An Ancient Mechanism for Novel Therapeutics. The Internet Journal of Genomics and Proteomics. https://doi.org/10.5580/13ef
Vancouver
RNA interference: An Ancient Mechanism for Novel Therapeutics. The Internet Journal of Genomics and Proteomics. 2007. doi:10.5580/13ef
BibTeX
@article{euvimed2007,
title = {RNA interference: An Ancient Mechanism for Novel Therapeutics},
journal = {The Internet Journal of Genomics and Proteomics},
year = {2007},
doi = {10.5580/13ef}
}
EUVIMED